Inventor · New York, NY, US

Michael R. McDevitt

16Patents
3h-index
23Co-inventors
60Inventor score

Filing activity: Nov 24, 2000 → Feb 26, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US6683162B2 Targeted alpha particle therapy using actinium-255 conjugates Human Necessities 32 Expired
US6603127B1 Bismuth-213 generator and uses thereof Physics 11 Expired
US8540965B2 Single wall nanotube constructs and uses therefor Chemistry; Metallurgy 4 Active
US9629927B2 Single wall nanotube constructs and uses thereof Chemistry; Metallurgy 2 Active
US9976137B2 Targeted self-assembly of functionalized carbon nanotubes on tumors Emerging Cross-Sectional Technologies 1 Active
US7736651B1 Alpha emitting constructs and uses thereof Chemistry; Metallurgy 1 Expired
US9289519B2 Alpha emitting constructs and uses thereof Chemistry; Metallurgy 1 Active
US12343407B2 Inflammasome-targeted RNA interference approach to treating kidney injury and disease Physics 0 Active
US11564988B2 Single wall nanotube constructs and uses thereof Chemistry; Metallurgy 0 Active
US11185501B2 Method and composition for targeted delivery of therapeutic agents Chemistry; Metallurgy 0 Active
US8486409B2 Alpha-emitting constructs and uses thereof Chemistry; Metallurgy 0 Active
US10406236B2 Single wall nanotube constructs and uses thereof Chemistry; Metallurgy 0 Active
US10900037B2 Targeted self-assembly of functionalized carbon nanotubes on tumors Emerging Cross-Sectional Technologies 0 Active
US11660357B2 One-step labeling of antibodies to high specific activity with actinium-225 Human Necessities 0 Active
US10794332B2 Microfluidic homogeneous catalyzation systems and methods, and apparatuses incorporating same Performing Operations; Transporting 0 Active
US11565005B2 Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.